Goldman Sachs Group Inc Alvotech Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
A detailed history of Goldman Sachs Group Inc transactions in Alvotech stock. As of the latest transaction made, Goldman Sachs Group Inc holds 44,372 shares of ALVO stock, worth $397,129. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,372
Previous 36,444
21.75%
Holding current value
$397,129
Previous $352,000
14.77%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ALVO
# of Institutions
53Shares Held
16.4MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA4.23MShares$37.9 Million0.0% of portfolio
-
Bracebridge Capital, LLC2.71MShares$24.2 Million14.1% of portfolio
-
Howard Marks Oaktree Capital Management LP | Los Angeles, Ca1.56MShares$14 Million0.39% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.39MShares$12.4 Million0.0% of portfolio
-
Littlejohn & CO LLC1.32MShares$11.8 Million11.48% of portfolio
About Alvotech
- Ticker ALVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 248,650,000
- Market Cap $2.23B
- Description
- Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory condi...